Validity |
Primary guides |
   Did the analysis provide a full economic comparison of health care |
    strategies? |
   Were all relevant costs and outcomes properly measured and valued? |
Secondary guides |
   Was appropriate allowance made for uncertainties in the analysis? |
   Are estimates of costs and outcomes related to the baseline risk in |
    the treatment population? |
What were the results? |
What were the incremental costs and outcomes of each strategy? |
Do incremental costs and outcomes differ between subgroups? |
How much does allowance for uncertainty change the results? |
Clinical application |
Are the treatment benefits worth the costs and potential harms? |
Could my patients expect similar health outcomes from using the |
   intervention? |
Could I expect similar costs? |